Company Filing History:
Years Active: 2019-2020
Title: Innovations of Anna Smith
Introduction
Anna Smith is an accomplished inventor based in St. Peters, MO (US). She has made significant contributions to the field of medical therapies, particularly in the area of atherosclerosis treatment. With a total of 2 patents, her work is paving the way for new therapeutic approaches.
Latest Patents
Anna's latest patents include "Pulsed introduction of low-dose RANKL as a therapy for diet-induced atherosclerosis" and "Systems and methods for inhibiting atherosclerosis using FoxP3+ CD8 T-cells (Tc)." These patents focus on the innovative use of RANKL, a RANK agonist, to induce osteoclasts to produce FoxP3+ CD8 T-cells. The research highlights that the effectiveness of RANKL is maximized when administered in a pulsed manner.
Career Highlights
Anna Smith is affiliated with Saint Louis University, where she conducts her research and develops her inventions. Her work has garnered attention for its potential to transform treatment protocols for atherosclerosis, a condition that affects millions worldwide.
Collaborations
Some of Anna's notable coworkers include Rajeev Aurora and Angel Baldan, who contribute to her research efforts and help advance her innovative projects.
Conclusion
Anna Smith's contributions to medical innovation, particularly in the treatment of atherosclerosis, demonstrate her commitment to improving health outcomes. Her patents reflect a promising future for therapeutic strategies in this critical area of medicine.